NO980127L - Anvendelse av ipriflavon for å redusere antall CD8+ celler - Google Patents

Anvendelse av ipriflavon for å redusere antall CD8+ celler

Info

Publication number
NO980127L
NO980127L NO980127A NO980127A NO980127L NO 980127 L NO980127 L NO 980127L NO 980127 A NO980127 A NO 980127A NO 980127 A NO980127 A NO 980127A NO 980127 L NO980127 L NO 980127L
Authority
NO
Norway
Prior art keywords
cells
ipriflavone
reduce
isopropoxyisoflavone
lymphocytes
Prior art date
Application number
NO980127A
Other languages
English (en)
Norwegian (no)
Other versions
NO980127D0 (no
Inventor
Attila B Kovacs
Peter Aranyi
Terezia Kerepesi
Gyoergy Varai
Attila Tar
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO980127D0 publication Critical patent/NO980127D0/no
Publication of NO980127L publication Critical patent/NO980127L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
NO980127A 1995-07-21 1998-01-12 Anvendelse av ipriflavon for å redusere antall CD8+ celler NO980127L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (2)

Publication Number Publication Date
NO980127D0 NO980127D0 (no) 1998-01-12
NO980127L true NO980127L (no) 1998-01-12

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980127A NO980127L (no) 1995-07-21 1998-01-12 Anvendelse av ipriflavon for å redusere antall CD8+ celler

Country Status (22)

Country Link
EP (1) EP0841915A1 (de)
JP (1) JP2001503371A (de)
KR (1) KR19990028933A (de)
CN (1) CN1191483A (de)
AR (1) AR002905A1 (de)
AU (1) AU6367096A (de)
BG (1) BG102182A (de)
BR (1) BR9610187A (de)
CA (1) CA2227421A1 (de)
CZ (1) CZ2798A3 (de)
EA (1) EA199800146A1 (de)
EE (1) EE9800020A (de)
HR (1) HRP960345A2 (de)
HU (1) HU9502198D0 (de)
IL (1) IL122751A0 (de)
MX (1) MX9800603A (de)
NO (1) NO980127L (de)
PL (1) PL324460A1 (de)
SK (1) SK3298A3 (de)
WO (1) WO1997003664A1 (de)
YU (1) YU42796A (de)
ZA (1) ZA966079B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
HRP960345A2 (en) 1998-02-28
IL122751A0 (en) 1998-08-16
EE9800020A (et) 1998-08-17
BG102182A (en) 1998-08-31
NO980127D0 (no) 1998-01-12
EP0841915A1 (de) 1998-05-20
HU9502198D0 (en) 1995-09-28
PL324460A1 (en) 1998-05-25
CZ2798A3 (cs) 1998-06-17
MX9800603A (es) 1998-04-30
KR19990028933A (ko) 1999-04-15
AR002905A1 (es) 1998-04-29
SK3298A3 (en) 1998-07-08
JP2001503371A (ja) 2001-03-13
EA199800146A1 (ru) 1998-08-27
CN1191483A (zh) 1998-08-26
YU42796A (sh) 1999-03-04
WO1997003664A8 (en) 1999-08-05
WO1997003664A1 (en) 1997-02-06
AU6367096A (en) 1997-02-18
CA2227421A1 (en) 1997-02-06
ZA966079B (en) 1998-01-19
BR9610187A (pt) 1998-07-28

Similar Documents

Publication Publication Date Title
NO854211L (no) Farmasoeytisk blanding og fremgangsmaate til behandling av legemet.
HK1007102A1 (en) Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
SE9704870D0 (sv) New pharmaceutical formulation I
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
ATE215827T1 (de) Immunologische aktivität der rhamnolipide
RU94044436A (ru) Способы подавления атрофии кожи и влагалища
CA2015838A1 (en) Method of topically treating acne vulgaris
DK0957906T3 (da) Lokalanæstetisk middel til udvortes brug
NO994640L (no) Hostestillende midler
ATE15596T1 (de) Pharmazeutische mittel.
ES8100883A1 (es) Procedimiento para la produccion de un preparado farmaceuti-co
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
AU2002216748A1 (en) Method of treatment of seborrheic dermatitis
NO996049L (no) Farmasoeytisk preparat med kontrollert frigjoering, med ACE- inhibitor som aktiv ingrediens
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
KR880007068A (ko) 13-시스 레티노산의 용도
NO980127L (no) Anvendelse av ipriflavon for å redusere antall CD8+ celler
AU574534B2 (en) Anticoccidial compositions
NO950950L (no) Farmasöytisk preparat
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
NO932097L (no) Myke farmasoeytiske kapsler som inneholder lysinclonixinat og fremgangsmaate for deres fremstilling
CO4750838A1 (es) Metodo para el tratamiento de reacciones inflamatorias adversas y la composicion antiinflamatoria administrada
DK0654042T3 (da) Amylinmuteiner
CA2153570A1 (en) Pharmaceutical composition for treating nicotine dependence